Levofloxacine Eg (Levofloxacin)

Levofloxacin blocks two essential bacterial enzymes, DNA gyrase and topoisomerase IV, which are required for DNA replication and transcription. By binding to these enzymes, the drug prevents the resealing of DNA strands, leading to bacterial cell death and a bactericidal effect against many Gram‑positive and Gram‑negative organisms.

The specific dose and duration of Levofloxacine Eg are determined by the prescribing clinician based on the type and severity of the infection, patient age, renal function and other clinical factors. Patients should follow the exact regimen provided by their healthcare professional.

Levofloxacine Eg falls under an unknown pregnancy category, and safety data are limited. It should be used only if the potential benefits justify the possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levofloxacin is a third‑generation fluoroquinolone with a broader spectrum against Gram‑positive organisms and better lung penetration compared with ciprofloxacin. Both share similar safety profiles, but levofloxacin often requires once‑daily dosing, whereas ciprofloxacin may need twice‑daily administration, which can affect patient adherence.

Levofloxacine Eg should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Levofloxacine Eg is taken orally, usually with a full glass of water. It can be taken with or without food, but if antacids or supplements containing aluminum, magnesium, calcium or iron are used, they should be spaced at least two hours apart to avoid reduced absorption.

Serious adverse events include tendon rupture (especially Achilles), QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, peripheral neuropathy, and hepatic injury. Patients should seek immediate medical attention if they experience sudden joint pain, palpitations, rash, severe diarrhea or signs of liver dysfunction.

Levofloxacine Eg is contraindicated in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones. It should be avoided in patients with a history of tendon disorders related to fluoroquinolone use, those with prolonged QT interval without proper monitoring, and in pregnant or breastfeeding women unless the benefit outweighs the risk. Pediatric use is limited to specific indications approved by regulatory authorities.